Search

Find exactly what you’re looking for.
Search

Service
Insights
Showing 1-7 of 7 results

The federal Corporate Transparency Act (“CTA”) requires that corporations submit a report to the Financial Crimes Enforcement Network (“FinCEN”) before January 1, 2025, with information on the persons who exercise substantial control over the corporation. As currently in place, condominium and...

Charles Kelly

Charles Kelly is a highly regarded litigator with extensive experience handling media, health care and complex commercial litigation. He regularly litigates cases in federal, state and bankruptcy courts. Charlie's clients range from Fortune 100 to small start-up companies that he represents for...

Peter S. Murphy

Peter Murphy advises domestic and international clients on a variety of corporate and commercial matters, including transactions and governance matters. Peter also leads the firm’s Corporate Transparency Act (CTA) Team, which guides domestic and foreign entities registered in the United States to...

Maria Carnicella

Maria Carnicella advises clients on mergers and acquisitions and other major corporate transactions. In addition to M&A deals, she represents private and public entities and individual investors in stock and asset sales and acquisitions, private placements, reorganizations, IPOs, redemptions, and...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...

Jay Reilly Headshot

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

For More Information
Contact us